Attached files

file filename
10-K - ANNUAL REPORT - HELIX BIOMEDIX INChelix_10k-123110.htm
EX-32.2 - HELIX BIOMEDIX INCex32-2.htm
EX-31.1 - HELIX BIOMEDIX INCex31-1.htm
EX-23.1 - HELIX BIOMEDIX INCex23-1.htm
EX-31.2 - HELIX BIOMEDIX INCex31-2.htm
EX-10.21 - HELIX BIOMEDIX INCex10-21.htm
EX-10.1(D) - HELIX BIOMEDIX INCex10-1d.htm
EX-10.1(B) - HELIX BIOMEDIX INCex10-1b.htm
EX-10.3(D) - HELIX BIOMEDIX INCex10-3d.htm
EX-10.1(C) - HELIX BIOMEDIX INCex10-1c.htm
EX-10.11(A) - HELIX BIOMEDIX INCex10-11a.htm
EX-10.17(A) - HELIX BIOMEDIX INCex10-17a.htm
EX-10.14(C) - HELIX BIOMEDIX INCex10-14c.htm
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350
 
I, R. Stephen Beatty, President and Chief Executive Officer of Helix BioMedix, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
1.
the Annual Report on Form 10-K of the Company for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: March 24, 2011
 
   
 
/s/ R. Stephen Beatty
 
R. Stephen Beatty
President and Chief Executive Officer